These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8284258)

  • 1. Vasoactive intestinal peptide (VIP) causes memory impairment in passive avoidance responding of the rat.
    Takashima A; Maeda Y; Itoh S
    Peptides; 1993; 14(5):1067-71. PubMed ID: 8284258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memory effect of caerulein and its analogs in active and passive avoidance responses in the rat.
    Itoh S; Takashima A; Igano K; Inouye K
    Peptides; 1989; 10(4):843-8. PubMed ID: 2531375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of chronic intracerebroventricular infusion of vasoactive intestinal peptide (VIP) on memory processes in Morris water pool test in the rat.
    Takashima A; Maeda Y; Itoh S
    Peptides; 1993; 14(5):1073-8. PubMed ID: 8284259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide (VIP): an amnestic neuropeptide.
    Flood JF; Garland JS; Morley JE
    Peptides; 1990; 11(5):933-8. PubMed ID: 2178250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired spatial learning by vasoactive intestinal peptide in Morris water maze task in the rat.
    Itoh S; Takashima A; Morimoto T
    Can J Physiol Pharmacol; 1994 Jan; 72(1):25-9. PubMed ID: 8012894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of cerulein on memory impairment induced by protein synthesis inhibitors in rats.
    Itoh S; Takashima A; Maeda Y
    Peptides; 1992; 13(5):1007-12. PubMed ID: 1480506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vasoactive intestinal peptide (VIP) on scopolamine-induced amnesia in the rat.
    Yamaguchi Y; Kobayashi H
    Neuropeptides; 1994 Mar; 26(3):153-8. PubMed ID: 8208360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lateralized hippocampal effects of vasoactive intestinal peptide on learning and memory in rats in a model of depression.
    Ivanova M; Belcheva S; Belcheva I; Negrev N; Tashev R
    Psychopharmacology (Berl); 2012 Jun; 221(4):561-74. PubMed ID: 22160165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel peptide VIP-TAT with higher affinity for PAC1 inhibited scopolamine induced amnesia.
    Yu R; Yang Y; Cui Z; Zheng L; Zeng Z; Zhang H
    Peptides; 2014 Oct; 60():41-50. PubMed ID: 25086267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of caerulein on decreased latency of passive avoidance response in rats treated with NMDA receptor antagonists.
    Takashima A; Maeda Y; Itoh S
    Peptides; 1990; 11(6):1263-7. PubMed ID: 1982352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory avoidance memory deficit induced by scopolamine: interaction with glutamatergic system in the nucleus accumbens.
    Pakpour B; Ahmadi S; Nayer-Nouri T; Oryan S; Zarrindast MR
    Behav Pharmacol; 2010 Dec; 21(8):719-26. PubMed ID: 20926947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of V-9-M, a peptide fragment derived from procholecystokinin, on memory processes in the rat.
    Takashima A; Itoh S
    Can J Physiol Pharmacol; 1989 Mar; 67(3):228-31. PubMed ID: 2743209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics and toxicity of vasoactive intestinal peptide for intranasal administration.
    Cui X; Cao DY; Wang ZM; Zheng AP
    Pharmazie; 2013 Jan; 68(1):69-74. PubMed ID: 23444784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin-related peptides, after systemic or central administration, prevent carbon monoxide-induced amnesia in mice.
    Maurice T; Hiramatsu M; Kameyama T; Hasegawa T; Nabeshima T
    J Pharmacol Exp Ther; 1994 May; 269(2):665-73. PubMed ID: 8182534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral actions of vasoactive intestinal peptide (VIP).
    Cottrell GA; Veldhuis HD; Rostene WH; de Kloet ER
    Neuropeptides; 1984 Jun; 4(4):331-41. PubMed ID: 6089028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraventricular infusions of anti-NCAM PSA impair the process of consolidation of both avoidance conditioning and spatial learning paradigms in Wistar rats.
    Seymour CM; Foley AG; Murphy KJ; Regan CM
    Neuroscience; 2008 Dec; 157(4):813-20. PubMed ID: 18948173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic projection to the central amygdala mediates the facilitatory effect of CCK-8US and caerulein on memory in rats.
    Winnicka MM; Wiśniewski K
    Pharmacol Res; 1999 Jun; 39(6):445-50. PubMed ID: 10373247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ligands that increase cAMP on caerulein-induced zymogen activation in pancreatic acini.
    Lu Z; Kolodecik TR; Karne S; Nyce M; Gorelick F
    Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G822-8. PubMed ID: 12881228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of cholecystokinin, beta-endorphin, and their antagonists on passive avoidance behavior in rats.
    Itoh S; Katsuura G; Takashima A
    Can J Physiol Pharmacol; 1987 Nov; 65(11):2260-4. PubMed ID: 2966663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.